Random PCR mutagenesis screening of secreted proteins by direct expression in mammalian cells.
- 15 June 1992
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 89 (12) , 5467-5471
- https://doi.org/10.1073/pnas.89.12.5467
Abstract
We have developed a general method for screening randomly mutagenized expression libraries in mammalian cells by using fluorescence-activated cell sorting (FACS). The cDNA sequence of a secreted protein is randomly mutagenized by PCR under conditions of reduced Taq polymerase fidelity. The mutated DNA is inserted into an expression vector encoding the membrane glycophospholipid anchor sequence of decay-accelerating factor (DAF) fused to the C terminus of the secreted protein. This results in expression of the protein on the cell surface in transiently transfected mammalian cells, which can then be screened by FACS. This method was used to isolate mutants in the kringle 1 (K1) domain of tissue plasminogen activator (t-PA) that would no longer be recognized by a specific monoclonal antibody (mAb387) that inhibits binding of t-PA to its clearance receptor. DNA sequence analysis of the mutants and localization of the mutated residues on a three-dimensional model of the K1 domain identified three key discontinuous amino acid residues that are essential for mAb387 binding. Mutants with changes in any of these three residues were found to have reduced binding to the t-PA receptor on human hepatoma HepG2 cells but to retain full clot lysis activity.Keywords
This publication has 19 references indexed in Scilit:
- Selective extraction of polyoma DNA from infected mouse cell culturesPublished by Elsevier ,2004
- [19] Rapid and efficient site-specific mutagenesis without phenotypic selectionPublished by Elsevier ,2004
- Measurement of transient cDNA expression in mammalian cells using flow cytometric cell analysis and sortingCytometry, 1991
- Tissue Plasminogen Activator: The Biochemistry and Pharmacology of Variants Produced by MutagenesisAnnual Review of Pharmacology and Toxicology, 1990
- Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2Journal of Biological Chemistry, 1989
- Structure-function analysis with tissue-type plasminogen activator. Effect of deletion of NH2-terminal domains on its biochemical and biological properties.Journal of Biological Chemistry, 1988
- Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombinProteins-Structure Function and Bioinformatics, 1988
- Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2)Nature, 1987
- Strategies and Applications of in Vitro MutagenesisScience, 1985
- CATABOLISM OF HUMAN-TISSUE PLASMINOGEN-ACTIVATOR IN MICE1985